Post by Novartis Europe
3,800 followers
Europe already has the science, the talent, and the research excellence. The EU Biotech Act is an opportunity to turn these strengths into faster breakthroughs and better outcomes for patients. Hear our team's perspective on what the Biotech Act could mean for patients and for Europe's global health leadership. 🎥Featuring Alexandra Tamas (Director, EU Public Affairs) Hugh Pullen (Head, Region Europe, Public Affairs) and Aoiffe O'Brien, (Executive Director Policy and Portfolio Advocacy, Europe) #NovartisEurope #EUBiotechAct
Video Content